San Francisco, CA, United States of America

Maithili Rairkar

USPTO Granted Patents = 4 

Average Co-Inventor Count = 9.6

ph-index = 1


Company Filing History:


Years Active: 2021-2023

Loading Chart...
4 patents (USPTO):

Title: Maithili Rairkar: Innovator in Drug Delivery Systems

Introduction

Maithili Rairkar is a prominent inventor based in San Francisco, CA, known for her significant contributions to the field of drug delivery systems. With a total of four patents to her name, she has made remarkable advancements in the treatment of various diseases, particularly in the area of prostate cancer.

Latest Patents

Rairkar's latest patents include innovative drug implants that utilize enzalutamide for the treatment of diseases. These drug implants are designed with a polymer matrix that effectively delivers the therapeutic agent to the subject. Additionally, she has developed methods for manufacturing these implants and treating diseases with them. Another notable patent involves implantable drug delivery devices that contain a therapeutically active agent, which may include bicalutamide for prostate cancer treatment. These advancements highlight her commitment to improving patient care through innovative drug delivery solutions.

Career Highlights

Throughout her career, Maithili Rairkar has worked with esteemed organizations such as the University of California and Alessa Therapeutics, Inc. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in drug delivery technologies.

Collaborations

Rairkar has collaborated with notable colleagues, including Pujan Desai and Carlos Schuler, further enhancing her research and development efforts in the pharmaceutical industry.

Conclusion

Maithili Rairkar's innovative work in drug delivery systems has positioned her as a key figure in the field of pharmaceuticals. Her patents and collaborations reflect her dedication to advancing medical treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…